PLOS ONE | www.plosone.org 1
December 2013 | Volume 8 | Issue 12 | e82027
Further analysis of the 2011 Nepal Demographic and Health Survey
Vitamin A supplementation (VAS) programs targeted at children aged 6–59 months are implemented in many countries. By improving immune function, vitamin A (VA) reduces mortality associated with measles, diarrhea, and other illnesses. There is currently a debate regarding the relevance of VAS, but a...midst the debate, researchers acknowledge that the majority of nationally-representative data on VA status is outdated. To address this data gap and contribute to the debate, we examined data from 82 countries implementing VAS programs, identified other VA programs, and assessed the recentness of national VA deficiency (VAD) data.
Article published in: Nutrients, 2017, 9, 190
https://doi.org/10.3390/nu9030190
more
July 2019
Policy brief
HIV Treatment
Evaluation Report
Evaluation Office
The 5 years plan to scale up HIV Testing and Counselling Services in Malawi 2006-2010
This research report provides results from the study on living conditions among people with disabilities in Zambia. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Zambia are also compar...ed to those obtained in earlier studies carried out in Namibia, Zimbabwe and Malawi. The Zambian study was undertaken in 2005-2006.
more
White Paper from the National Child Traumatic Stress Network Refugee Trauma Task Force
BMC Medicine201614:112 DOI: 10.1186/s12916-016-0660-0
Global Health Science and Practice. First published online November 12, 2015
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.